The use, appropriateness and outcomes of outpatient parenteral antimicrobial therapy

被引:46
|
作者
Hodgson, Kate A. [1 ]
Huynh, Julie [1 ]
Ibrahim, Laila F. [1 ]
Sacks, Bronwyn [1 ]
Golshevsky, Daniel [1 ]
Layley, Michael [1 ]
Spagnolo, Mark [1 ]
Raymundo, Chin-Mae [1 ]
Bryant, Penelope A. [1 ,2 ,3 ,4 ]
机构
[1] Royal Childrens Hosp Melbourne, RCH Home Dept, Parkville, Vic, Australia
[2] Royal Childrens Hosp Melbourne, Dept Gen Med, Infect Dis Unit, Parkville, Vic, Australia
[3] Royal Childrens Hosp Melbourne, Murdoch Childrens Res Inst, Clin Paediat Grp, Parkville, Vic, Australia
[4] Univ Melbourne, Dept Paediat, Royal Childrens Hosp Melbourne, Parkville, Vic, Australia
关键词
RISK FEBRILE NEUTROPENIA; ANTIBIOTIC-THERAPY; CYSTIC-FIBROSIS; CHILDREN; HOME; MANAGEMENT; METAANALYSIS; CHILDHOOD; CARE;
D O I
10.1136/archdischild-2015-309731
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective Outpatient parenteral antimicrobial therapy (OPAT) is increasingly used to treat children at home, but studies in children are scarce. We aimed to describe the use, appropriateness and outcomes of OPAT in children. Design This was a 12-month prospective observational study. Setting The hospital-in-the-home programme of The Royal Children's Hospital Melbourne. Patients All patients receiving OPAT. Interventions Data were collected including demographics, diagnosis, type of venous access and antibiotic choice. Main outcome measures Length of stay, adverse events, readmission rate and appropriateness of antibiotic use. Results 228 patients received OPAT in 251 episodes. The median age was 7.4 years (range 1 week to 21 years), with 22 patients (10%) under 1 year. The most frequent diagnoses were exacerbation of cystic fibrosis (17%), urinary tract infection (12%) and cellulitis (9%). Most patients were transferred from the ward, but 18% were transferred directly from the emergency department, the majority with skin and soft-tissue infection (66%). Venous access was most commonly peripherally inserted central catheter (29%) and peripheral cannula (29%). 309 parenteral antibiotics were prescribed, most frequently ceftriaxone (28%) and gentamicin (19%). The majority of antibiotics (72%) were prescribed appropriately. However, 6% were deemed an inappropriate choice for the indication and 26% had inappropriate dose or duration. The incidence of central line-associated bloodstream infections was 0.9%. The unplanned readmission rate was 4%, with low rates of OPAT-related adverse events. Three children (1%) had an inadequate clinical response. Conclusions OPAT is a safe and effective way of providing antibiotics to children. Despite high rates of appropriate antibiotic use, improvements can still be made.
引用
收藏
页码:886 / 893
页数:8
相关论文
共 50 条
  • [31] Outcomes According to Discharge Location for Persons Who Inject Drugs Receiving Outpatient Parenteral Antimicrobial Therapy
    D'Couto, Helen T.
    Robbins, Gregory K.
    Ard, Kevin L.
    Wakeman, Sarah E.
    Alves, Justin
    Nelson, Sandra B.
    OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (05):
  • [32] Use of Ceftriaxone and Benzylpenicillin in Outpatient Parenteral Antimicrobial Therapy: Spectrum vs Cost
    Kalatharan, L.
    Ferman, M.
    Kumar, S.
    Rajendra, S.
    Pripanapong, S.
    Wu, Y.
    Richards, H.
    Rogers, B. A.
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (11):
  • [33] Safety and efficacy of outpatient parenteral antimicrobial therapy: A systematic review and meta-analysis of randomized clinical trials
    Mohammed, Solomon Ahmed
    Roberts, Jason A.
    Cotta, Menino Osbert
    Rogers, Benjamin
    Pollard, James
    Assefa, Getnet Mengistu
    Erku, Daniel
    Sime, Fekade B.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 64 (02)
  • [34] Effectiveness of telemedicine in outpatient parenteral antimicrobial therapy (Tele-OPAT): A systematic review
    Durojaiye, Oyewole Christopher
    Jibril, Ihsan
    Kritsotakis, Evangelos, I
    JOURNAL OF TELEMEDICINE AND TELECARE, 2024, 30 (08) : 1230 - 1237
  • [35] Safety of Nurse- and Self-Administered Paediatric Outpatient Parenteral Antimicrobial Therapy
    Sriskandarajah, Shanthy
    Ritchie, Brett
    Sluggett, Janet K.
    Hobbs, Jodie G.
    Reynolds, Karen J.
    ANTIBIOTICS-BASEL, 2020, 9 (11): : 1 - 12
  • [36] Oral antimicrobial therapy for cellulitis versus outpatient parenteral antimicrobial therapy: a single-centre audit of cellulitis outcomes
    Bowhay, Thomas R. R.
    Tsang, Tiffany
    Wei, Jeremy C. Z.
    Edwik, Wafa
    Fridman, Avi
    Hubber, Julia
    Jo, Jae Y. Y.
    Mckay, Nicole
    O'Brien, Catherine
    Osmond-Wallam, Joe
    Smythe, James
    Crump, John A. A.
    Arnold, Brendan
    INTERNAL MEDICINE JOURNAL, 2024, 54 (02) : 320 - 327
  • [37] A single centre experience of prosthetic joint infection outcomes with outpatient parenteral antimicrobial therapy
    Kutubi, Abdubadie
    O'Brien, Luke
    Murphy, Ben
    Fitzpatrick, Patricia
    Hurson, Conor
    Rajendran, Deepa
    Feeney, Eoin
    Mallon, Patrick
    Waqas, Sarmad
    HELIYON, 2023, 9 (04)
  • [38] Effectiveness of outpatient parenteral antimicrobial therapy (OPAT) for patients with cranial infection
    Kilinc, Fatma
    Setzer, Matthias
    Behmanesh, Bedjan
    Jussen, Daniel
    Gessler, Florian
    Bayerl, Simon
    Kempf, Volkhard A. J.
    Kessel, Johanna
    Czabanka, Marcus
    Prinz, Vincent
    FRONTIERS IN MEDICINE, 2023, 10
  • [39] Safety and feasibility of outpatient parenteral antimicrobial therapy for patients with spinal infection
    Kilinc, Fatma
    Setzer, Matthias
    Behmanesh, Bedjan
    Jussen, Daniel
    Gessler, Florian
    Keil, Fee
    Kempf, Volkhard A. J.
    Kessel, Johanna
    Czabanka, Marcus
    Prinz, Vincent
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [40] Low Use of Outpatient Parenteral Antimicrobial Therapy for Drug Use-Associated Infective Endocarditis in an Urban Hospital System
    Ceniceros, Ashley G.
    Shridhar, Nupur
    Fazzari, Melissa
    Felsen, Uriel
    Fox, Aaron D.
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (03):